ES2151476T3 - Formulaciones de farmacos en aerosol. - Google Patents

Formulaciones de farmacos en aerosol.

Info

Publication number
ES2151476T3
ES2151476T3 ES91912299T ES91912299T ES2151476T3 ES 2151476 T3 ES2151476 T3 ES 2151476T3 ES 91912299 T ES91912299 T ES 91912299T ES 91912299 T ES91912299 T ES 91912299T ES 2151476 T3 ES2151476 T3 ES 2151476T3
Authority
ES
Spain
Prior art keywords
aerosol
formulations
pharmacos
tetrafluoroethane
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91912299T
Other languages
English (en)
Inventor
Keith A Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/649,405 external-priority patent/US5126123A/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Application granted granted Critical
Publication of ES2151476T3 publication Critical patent/ES2151476T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTAN FORMULACIONES PARA AEROSOL QUE COMPRENDEN UNA DROGA DE INHALACION, 1,1,1,2-TETRAFLUOROETANO (P134A) Y UN AGENTE ACTIVO DE SUPERFICIE SOLUBLE EN 1,1,1,2-TETRAFLUOROETANO.
ES91912299T 1990-06-28 1991-06-27 Formulaciones de farmacos en aerosol. Expired - Lifetime ES2151476T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54543790A 1990-06-28 1990-06-28
US07/649,405 US5126123A (en) 1990-06-28 1991-02-01 Aerosol drug formulations

Publications (1)

Publication Number Publication Date
ES2151476T3 true ES2151476T3 (es) 2001-01-01

Family

ID=27067939

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91912299T Expired - Lifetime ES2151476T3 (es) 1990-06-28 1991-06-27 Formulaciones de farmacos en aerosol.

Country Status (13)

Country Link
EP (1) EP0536250B1 (es)
JP (1) JP3056784B2 (es)
AT (1) ATE196076T1 (es)
AU (1) AU649702B2 (es)
CA (1) CA2083821A1 (es)
DE (1) DE69132407T2 (es)
ES (1) ES2151476T3 (es)
GB (1) GB2263064B (es)
IE (1) IE912246A1 (es)
IL (1) IL98639A0 (es)
NZ (1) NZ238749A (es)
PT (1) PT98105B (es)
WO (1) WO1992000107A1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
HUT67445A (en) * 1991-06-10 1995-04-28 Schering Corp Aerosol formulations containing 1,1,1,2-tetrafluorethane
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
DK0616524T3 (da) 1991-12-12 1999-06-21 Glaxo Group Ltd Lægemidler
ES2079210T3 (es) * 1991-12-12 1996-01-01 Glaxo Group Ltd Formulacion farmaceutica de aerosol.
GB9202522D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DK0731688T3 (da) * 1993-12-02 2003-06-23 Abbott Lab Aerosol-lægemiddelformuleringer til anvendelse med CFC-frie drivmidler
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9626960D0 (en) 1996-12-27 1997-02-12 Glaxo Group Ltd Valve for aerosol container
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ES2525087T5 (es) 2000-05-10 2018-06-28 Novartis Ag Polvos basados en fosfolípidos para administración de fármacos
US7905230B2 (en) 2001-05-09 2011-03-15 Novartis Ag Metered dose inhaler with lockout
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
WO2003013610A2 (en) 2001-08-03 2003-02-20 Glaxo Group Limited Surfactant compounds and uses thereof
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
CN101184522B (zh) 2005-05-18 2011-12-21 尼克塔治疗公司 用于支气管内治疗的阀、设备和方法
MX348936B (es) 2005-09-29 2017-07-03 Nektar Therapeutics Formulaciones de antibioticos, dosis unitarias, equipos y metodos.
GB0614621D0 (en) 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
GB0620700D0 (en) 2006-10-19 2006-11-29 3M Innovative Properties Co Metered dose valves and dispensers
DK2425820T3 (en) 2007-02-11 2015-07-13 Map Pharmaceuticals Inc A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
GB201118188D0 (en) 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
GB201210580D0 (en) 2012-06-14 2012-08-01 3M Innovative Properties Co Metered dose dispensing valve
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
US20210244896A1 (en) * 2018-06-13 2021-08-12 Puff-Ah Pty Ltd Apparatus for use in delivering respiratory drugs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
AU654813B2 (en) * 1990-03-23 1994-11-24 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
FR2660297B1 (fr) * 1990-03-30 1992-06-12 Coflexip Dispositif de suspension et dispositif de liaison comportant un tel dispositif de suspension.
DE69101639T2 (de) * 1990-06-27 1994-10-06 Minnesota Mining & Mfg Anwendung von löslichen fluorhaltigen tensiden zur herstellung von aerosol-präparaten mit dosierter abgabe.

Also Published As

Publication number Publication date
AU649702B2 (en) 1994-06-02
NZ238749A (en) 1993-07-27
ATE196076T1 (de) 2000-09-15
GB2263064A (en) 1993-07-14
EP0536250A4 (en) 1993-06-16
PT98105B (pt) 1998-11-30
GB2263064B (en) 1994-09-14
JP3056784B2 (ja) 2000-06-26
GB9223891D0 (en) 1993-04-21
PT98105A (pt) 1993-08-31
EP0536250A1 (en) 1993-04-14
AU8213591A (en) 1992-01-23
JPH05507935A (ja) 1993-11-11
IL98639A0 (en) 1992-07-15
DE69132407D1 (de) 2000-10-12
EP0536250B1 (en) 2000-09-06
DE69132407T2 (de) 2001-04-05
IE912246A1 (en) 1992-01-01
CA2083821A1 (en) 1991-12-29
WO1992000107A1 (en) 1992-01-09

Similar Documents

Publication Publication Date Title
ES2151476T3 (es) Formulaciones de farmacos en aerosol.
EP0995434A3 (en) Medicinal aerosol formulations
IL77467A (en) Drug-containing aerosol formulations comprising chlorofluorocarbon propellent
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
YU59192A (sh) Formulacija aerosola koje ne sadrže hlorofluorougljenična jedinjenja
YU59092A (sh) Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
NZ238739A (en) Aerosol formulations comprising a powdered drug, a hydrofluorocarbon propellant and a perfluoroalkylsulphonamidoalkylphosphate surface-active agent
PT918507E (pt) Formulacoes em aerossol
EP0636362A3 (en) Use of soluble fluorinated surfactants in the preparation of compositions for metered-dose aerosol.
GB9024365D0 (en) Medicaments
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
EP0373499A3 (en) Antiperspirant and deodorant
IL127366A0 (en) Insulin preparations containing NaCl
IT1126406B (it) 1,2,4,5-tetra-alchil-4-arilpiperidine e relative formulazioni farmaceutiche
HU904007D0 (en) Medical preparations providing regulated active agent discharge and processes for the preparation thereof
CA2026990A1 (en) Anti-hiv agent
ES2089357T3 (es) Formulacion medicinal en forma de aerosol.
DK0626173T3 (da) Aerosolpræparat indeholdende fusafungin
AU4847390A (en) Fluorinated flavone acetic acid
FI920222A0 (fi) Doseringsmedel innefattande en jonofor.
GB2162746A (en) Antiacidotic medicinal agent
IT1240352B (it) Formulazioni liposomiali di farmaci mucosecretolitici e/o broncopolmonari per applicazione aerosolica

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 536250

Country of ref document: ES